Research Applications
Exemestane is a potent irreversible aromatase inhibitor extensively studied in endocrinological research. This Euro-Pharmacies formulation provides 20mg tablets suitable for investigating aromatase enzyme inhibition mechanisms and estrogen biosynthesis pathways. Research applications include studying the irreversible binding characteristics to the CYP19A1 enzyme active site, examining tissue-specific estrogen production modulation, and evaluating downstream effects on estrogen-dependent cellular processes. Laboratories utilising this compound can investigate its structural similarities to androstenedione and its competitive substrate interactions. Stroid UK Shop maintains strict quality standards for all analytical compounds.
Molecular Properties and Research Specifications
As a steroidal aromatase inhibitor, exemestane demonstrates irreversible enzyme binding through suicide inhibition mechanisms. The 20mg tablet formulation enables precise analytical measurements for dose-response studies and enzyme kinetics research. This compound exhibits high specificity for the aromatase enzyme complex, making it valuable for researchers studying selective inhibition pathways. Its steroidal structure differentiates it from non-steroidal inhibitors, providing unique research opportunities for comparative enzyme interaction studies. Investigators examining aromatase inhibitor mechanisms find this formulation particularly suitable for controlled laboratory environments.
Technical Data Sheet
| Parameter | Value |
|---|---|
| Active Compound | Exemestane |
| Concentration | 20mg per tablet |
| Presentation | 50 tablets per bag |
| Manufacturer | Euro-Pharmacies |
| CAS Number | 107868-30-4 |
| Molecular Formula | C₂₀H₂₄O₂ |
| Molecular Weight | 296.40 g/mol |
| Storage Requirements | Room temperature, dry environment |
Research facilities studying hormone-related pathways often incorporate studies from selective androgen receptor modulators and peptide compounds to understand comprehensive endocrine interactions.
Laboratory Research Guidelines
Exemestane research requires careful consideration of its irreversible binding mechanism and extended duration of enzyme inhibition. Laboratory protocols should account for the compound’s androgenic metabolite formation and its implications in experimental design. Researchers investigating estrogen-dependent cell lines must consider the prolonged effects of irreversible aromatase inhibition when designing experimental timelines. Storage recommendations include maintaining tablets in dry conditions at room temperature to preserve compound stability and analytical reliability.
Important: This product is intended strictly for in-vitro research use only. Not for human consumption, therapeutic use, or any application outside controlled laboratory environments. Researchers must comply with institutional guidelines and applicable regulations.
